Eligible for Vaccination Against Influenza Completed Phase 1 / 2 Trials for Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen (DB14447)

IndicationStatusPhase
DBCOND0049621 (Eligible for Vaccination Against Influenza)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01248208FluMist in Egg Allergic PatientsPrevention